Avicenna.AI

UPTUNITY Aneurysm AI wins FDA 510(k) clearance for Bracco

Image
UPTUNITY Aneurysm AI wins FDA 510(k) clearance for Bracco

MILAN — November 13, 2026 -- Bracco and Avicenna.AI have received U.S. FDA 510(k) clearance for UPTUNITY | Aneurysm, AI software that flags suspected brain aneurysms larger than 3 mm on head CTA scans. The clearance comes about eight months after the two companies announced their partnership in March 2026.

It is the first product in Bracco's new UPTUNITY portfolio of clinical decision support tools, and the first of the company's AI offerings named in the announcement to interpret images. The existing AiMIFY, developed with Subtle Medical, enhances contrast in brain MRI.